Insider Holders & Insider Ownership - Atara Biotherapeutics Inc. (ATRA)

List of insiders holdings for Atara Biotherapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
SEIDENBERG BETH C
Director		2023-06-02 20:06:15195,189
1,877,044		2,072,233Form 4
Touchon Pascal
President and CEO		2024-03-06 18:19:431,910,652
0		1,910,652Form 4
Kleiner Perkins Caufield & Byers XV LLC
KPCB XV Associates LLC
KPCB XV Founders Fund LLC
10% Owner		2019-02-14 13:49:251,876,650
0		1,876,650Form 13G
Domain Partners VIII L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
SCHOEMAKER KATHLEEN K
VITULLO NICOLE
Halak Brian K
10% Owner		2016-01-19 16:03:051,641,542
0		1,641,542Form 13G
DAG Ventures Management V LLC
Cadeddu John J.
Goodrich R. Thomas
Pianim Nicholas K.
Chung Young J.
Williams Greg
DAG Ventures V-QP L.P.
DAG Ventures V L.P.
10% Owner		2019-02-07 16:45:001,581,166
0		1,581,166Form 13G
Nguyen AnhCo
EVP, Chief Sci. & Tech Officer		2024-03-06 18:18:57941,397
0		941,397Form 4
MARCUS JOEL S
Director		2019-03-19 16:19:257500
892,355		899,855Form 4
Murugan Amar
EVP, Chief Legal Officer		2024-03-06 18:18:12727,521
0		727,521Form 4
Hyllengren Eric J
EVP, CFO		2024-03-06 18:17:15674,319
0		674,319Form 4
Gallagher Carol Giltner
Director		2024-04-02 18:12:10629,608
0		629,608Form 4
Ciechanover Isaac E.
Chief Executive Officer		2019-05-31 16:16:00332,243
290,687		622,930Form 4
DOBMEIER ERIC
Director		2023-11-14 18:27:14563,325
0		563,325Form 4
Henrich Jill
EVP, Global Head RA & Quality		2024-03-06 18:16:07555,001
0		555,001Form 4
HEIDEN WILLIAM K
Director		2024-04-02 18:12:47359,000
0		359,000Form 4
Haqq Christopher
EVP, R&D & Chief Scientific Of		2019-02-19 17:08:22271,943
20,000		291,943Form 4
Dupont Jakob
EVP, Head of R&D		2023-03-06 18:46:39290,794
0		290,794Form 4
Banard Charlene A.
EVP, Chief Technical Officer		2023-05-18 20:17:21276,010
0		276,010Form 4
Fust Matthew K
Director		2024-04-02 18:13:10259,000
0		259,000Form 4
Yarema Kristin
Chief Commercial Officer		2022-03-03 19:02:35257,007
0		257,007Form 4
Soffer Gad
EVP & Chief Strategy Officer		2018-09-25 16:17:01243,966
0		243,966Form 4
Roncarolo Maria Grazia
Director		2024-04-02 18:12:27238,500
0		238,500Form 4
MALLIK AMEET
Director		2024-04-02 18:11:52227,500
0		227,500Form 4
Koppikar Utpal
Chief Financial Officer		2023-03-06 18:47:31181,978
0		181,978Form 4
Joshi Manher
EVP, Chief Medical Officer		2023-11-20 17:30:19171,284
0		171,284Form 4
Newell Joe
Chief Operations Officer		2021-11-18 17:54:29113,097
0		113,097Form 4
Clark Mitchall G.
EVP & Chief R & QA Officer		2018-05-21 18:32:34107,972
0		107,972Form 4
MCGRATH JOHN
EVP & Chief Financial Officer		2018-03-20 18:30:3688,762
0		88,762Form 4
Berger Dietmar
Global Head of R&D		2019-05-08 16:32:3285,678
0		85,678Form 4
Baynes Roy D.
Director		2022-06-27 16:48:0975,000
0		75,000Form 4
Turner Heather D
Former EVP, GC & Sec.		2018-02-12 21:00:0769,494
0		69,494Form 4
Kim Mina
Senior VP & General Counsel		2019-04-10 16:33:3066,389
0		66,389Form 4
Renaud Ronald C JR
Director		2022-06-27 16:48:0163,000
0		63,000Form 4
Porter Derrell
SVP, Head of Global Commercial		2019-03-27 17:17:2031,688
0		31,688Form 4
WEBER ECKARD
Director		2015-01-21 16:38:2525,000
0		25,000Form 4
DP VIII Associates L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
SCHOEMAKER KATHLEEN K
VITULLO NICOLE
Halak Brian K
10% Owner		2014-10-21 10:39:2615,890
0		15,890Form 4